Sarcoidosis with ocular and hypothalamic-pituitary manifestations.
D000328:Adult; D002747:Chlorpropamide / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000188:drug therapy; D005128:Eye Diseases / Q000188:drug therapy / Q000209:etiology; D005132:Eye Manifestations; D006801:Humans; D008171:Lung Diseases / Q000150:complications; D008206:Lymphatic Diseases / Q000150:complications; D008297:Male; D009461:Neurologic Manifestations; D009900:Optic Nerve / Q000503:physiopathology; D011239:Prednisolone / Q000627:therapeutic use; D012507:Sarcoidosis / Q000150:complications; D014605:Uveitis / Q000150:complications
D011239:Prednisolone; D002747:Chlorpropamide